第一作者机构：[1]Capital Med Univ, Natl Ctr Childrens Hlth, Hematol Oncol Ctr, Beijing, Peoples R China[2]Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Yang Ying,Wang Dong,Cui Lei,et al.SHORT-TERM EFFECTIVENESS AND SAFETY OF DABRAFENIB IN TREATMENT OF 18 CHINESE CHILDREN WITH BRAFV600E MUTATION-POSITIVE LANGERHANS CELL HISTIOCYTOSIS[J].PEDIATRIC BLOOD & CANCER.2020,67:S38-S39.
APA：
Yang, Ying,Wang, Dong,Cui, Lei,Li, Zhi-Gang,Ma, Hong-Hao...&Zhang, Rui.(2020).SHORT-TERM EFFECTIVENESS AND SAFETY OF DABRAFENIB IN TREATMENT OF 18 CHINESE CHILDREN WITH BRAFV600E MUTATION-POSITIVE LANGERHANS CELL HISTIOCYTOSIS.PEDIATRIC BLOOD & CANCER,67,
MLA：
Yang, Ying,et al."SHORT-TERM EFFECTIVENESS AND SAFETY OF DABRAFENIB IN TREATMENT OF 18 CHINESE CHILDREN WITH BRAFV600E MUTATION-POSITIVE LANGERHANS CELL HISTIOCYTOSIS".PEDIATRIC BLOOD & CANCER 67.(2020):S38-S39
